Docetaxel

Nchi: Nyuzilandi

Lugha: Kiingereza

Chanzo: Medsafe (Medicines Safety Authority)

Viambatanisho vya kazi:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Inapatikana kutoka:

REX Medical Ltd

INN (Jina la Kimataifa):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Kipimo:

80 mg/mL

Dawa fomu:

Concentrate for infusion

Tungo:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Vitengo katika mfuko:

Vial, glass, Diluent, 6 mL

Darasa:

Prescription

Dawa ya aina:

Prescription

Viwandani na:

Cipla Ltd

Matibabu dalili:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Bidhaa muhtasari:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Idhini ya tarehe:

2006-06-23